Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies

OBJECTIVE: After an initially successful islet cell transplantation, a number of patients return to C-peptide negativity, and therefore immunosuppressive therapy is discontinued. Some are then found to have developed Graves disease. We examined the risk of Graves disease after immunosuppression. RES...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gillard, Pieter, Huurman, Volkert, Van der Auwera, Bart, Decallonne, Brigitte, Poppe, Kris, Roep, Bart O., Gorus, Frans, Mathieu, Chantal, Pipeleers, Daniel, Keymeulen, Bart
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Diabetes Association 2009
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2752930/
https://ncbi.nlm.nih.gov/pubmed/19549735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-2339
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge